Disparities in time to treatment with oral antimyeloma medications.

Gasoyan H, Anwer F, Kovach JD, Casacchia NJ, Wang M, Valent J, Halpern MT, Rothberg MB.

Open source

DOI
10.1038/s41408-024-01128-1
Published
2024-08-23
Container
Blood Cancer J
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41408-024-01128-1,
  title = {Disparities in time to treatment with oral antimyeloma medications.},
  author = {Gasoyan H and  Anwer F and  Kovach JD and  Casacchia NJ and  Wang M and  Valent J and  Halpern MT and  Rothberg MB.},
  year = {2024},
  journal = {Blood Cancer J},
  doi = {10.1038/s41408-024-01128-1},
  url = {https://doi.org/10.1038/s41408-024-01128-1}
}

RIS

TY  - JOUR
TI  - Disparities in time to treatment with oral antimyeloma medications.
AU  - Gasoyan H
AU  -  Anwer F
AU  -  Kovach JD
AU  -  Casacchia NJ
AU  -  Wang M
AU  -  Valent J
AU  -  Halpern MT
AU  -  Rothberg MB.
PY  - 2024
JO  - Blood Cancer J
DO  - 10.1038/s41408-024-01128-1
UR  - https://doi.org/10.1038/s41408-024-01128-1
ER  - 

APA

H, G., F, A., JD, K., NJ, C., M, W., J, V., MT, H., & MB., R. (2024). Disparities in time to treatment with oral antimyeloma medications.. Blood Cancer J. https://doi.org/10.1038/s41408-024-01128-1

Source records